Co-delivery of drugs and sirna to treat multidrug resistant tumor
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: TORCHILIN, Vladimir (Northeastern University, Center for Pharmaceutical Biotechnology, Boston, United States of America)
Tumor therapy, especially in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA down-regulating the production of proteins, which are involved in cancer cell resistance, such as Pgp or survivin. Even better response could be achieved is such siRNA could be delivered to tumors together with chemotherapeutic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.